2026-03-13T14:35:13+00:00 2025-06-30 135381590 BDO USA 200 PARK AVE 38TH FLOOR NEW YORK NY 10166 990 2024-07-01 133020943 SAMUEL WAXMAN CANCER RESEARCH FOUNDATION SAMU 2128674502 420 LEXINGTON AVENUE 825 NEW YORK NY 10170 Gerard J Joyce Board Secretary 2026-03-13 true PAUL HAMMERSCHMIDT P01384178 2128858000 2026-03-09 2024 2025-03-06 01:10:19Z Gerard J Joyce 420 LEXINGTON AVENUE 825 NEW YORK NY 10170 3959704 false X WWW.WAXMANCANCER.ORG X 1980 NY THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (THE "FOUNDATION") FUNDS INNOVATIVE RESEARCH TO BRING FASTER CURES TO PATIENTS. (CONTINUED ON SCHEDULE O) 25 24 5 95 0 2734459 2445014 0 0 26337 15467 100364 -250133 2861160 2210348 1637959 617500 0 0 1485168 1564566 52930 103395 692015 561272 521209 3737329 2806670 -876169 -596322 5376278 4595379 558705 279237 4817573 4316142 THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (THE "FOUNDATION") FUNDS INNOVATIVE RESEARCH TO BRING FASTER CURES TO PATIENTS. IN ADDITION TO SUPPORTING ONGOING COLLABORATIVE RESEARCH IN SPECIFIC CANCERS, OUR SCIENTISTS ARE INVESTIGATING THE BIOLOGY OF CANCER TO FIND TREATMENTS ACROSS THE DISEASE. false false 1662780 617500 0 THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION IS AN INTERNATIONAL ORGANIZATION DEDICATED TO CURING AND PREVENTING CANCER. THE FOUNDATION IS A PIONEER IN CANCER RESEARCH FOCUSING ON UNCOVERING THE CAUSES OF CANCER AND REPROGRAMMING CANCER CELLS. WE DEDICATE OURSELVES TO DELIVERING TAILORED, MINIMALLY TOXIC TREATMENTS TO PATIENTS. OUR MISSION IS TO ERADICATE CANCER BY BRIDGING THE GAP BETWEEN LAB SCIENCE AND THE PATIENT. THROUGH OUR COLLABORATIVE GROUP OF WORLD-CLASS SCIENTISTS, THE INSTITUTE WITHOUT WALLS, INVESTIGATORS SHARE INFORMATION AND TOOLS TO SPEED THE PACE OF CANCER RESEARCH. SINCE OUR INCEPTION IN 1976, THE FOUNDATION HAS AWARDED MORE THAN $120 MILLION TO SUPPORT THE WORK OF MORE THAN 200 RESEARCHERS ACROSS THE GLOBE. 1662780 true true false false false false false false false false true false false false true true true false false false false false false true true false false true false true false false false false false false false false false false true false false false false false false false false false true 31 0 true 5 true false false false false false true true false false false false false false X 25 24 true false false false false false false true true false false false true true true true true true true true false false NY X X X SAMUEL WAXMAN 2128674502 420 LEXINGTON AVENUE NEW YORK NY 10170 DENA K WEINER VICE-PRESIDENT 2.0 0.0 X X 0 0 0 GERARD J JOYCE SECRETARY 2.0 0.0 X X 0 0 0 MICHAEL NIERENBERG CHAIRMAN 2.0 0.0 X X 0 0 0 NICK SANTORO TREASURER (as of 07/01/2024) 2.0 0.0 X X 0 0 0 SAMUEL WAXMAN MD DIRECTOR-CEO 20.0 0.0 X X 250000 0 0 SPENCER WAXMAN PRESIDENT 2.0 0.0 X X 0 0 0 ARI ZAGDANSKI DIRECTOR 1.0 0.0 X 0 0 0 BARON SILVERSTEIN DIRECTOR 1.0 0.0 X 0 0 0 CHRISITNE ARLOTTA DIRECTOR 1.0 0.0 X 0 0 0 DENNIS A HERMAN DIRECTOR 1.0 0.0 X 0 0 0 ETHAN DMITROVSKY MD DIRECTOR 1.0 0.0 X 0 0 0 FREDRICK W BARNEY DIRECTOR 1.0 0.0 X 0 0 0 GARY JACOB DIRECTOR 1.0 0.0 X 0 0 0 GARY NOLAN DIRECTOR 1.0 0.0 X 0 0 0 HOWAD SHLAFMITZ DIRECTOR 1.0 0.0 X 0 0 0 JAMES FRANKEL DIRECTOR 1.0 0.0 X 0 0 0 JAMES A INGRAM DIRECTOR (THRU 02/01/2025) 1.0 0.0 X 0 0 0 JOSEPH STEFFA DIRECTOR 1.0 0.0 X 0 0 0 KENNETH FISHEL DIRECTOR (THRU 05/01/2025) 1.0 0.0 X 0 0 0 LEWIS A RUBIN DIRECTOR 1.0 0.0 X 0 0 0 LINDA HERMAN DIRECTOR 1.0 0.0 X 0 0 0 MARC TAUB DIRECTOR 1.0 0.0 X 0 0 0 PEEYUSH MISRA DIRECTOR 1.0 0.0 X 0 0 0 RIVA ARIELLA RITVO-SLIFKA DIRECTOR 1.0 0.0 X 0 0 0 SCOTT WAXMAN DIRECTOR 1.0 0.0 X 0 0 0 SUSEAN PERNICK DIRECTOR (AS OF 03/01/2025) 1.0 0.0 X 0 0 0 W DAVID HINKELMAN DIRECTOR 1.0 0.0 X 0 0 0 GREGORY FABIJANCZUK CFO/DIRECTOR OF FINANCE (thru 04/30/2025) 40.0 0.0 X 145613 0 42597 WILLIAM T SULLIVAN EXECUTIVE DIRECTOR 50.0 0.0 X 342514 0 88934 KAREN KIRK DIRECTOR OF SPECIAL EVENTS 40.0 0.0 X 121650 0 72628 Suzanna C Houston Director of Special Projects 40.0 0.0 X 130750 0 30999 WYLIE TENE DIRECTOR OF MARKETING & COMMUNICATION 40.0 0.0 X 140472 0 31981 1130999 0 267139 6 false true false ENTOURAGE 183 MADISON AVENUE NEW YORK NY 10016 GALA ENTERTAINMENT 258000 1 1987249 457765 58267 2445014 0 0 0 0 0 15467 0 0 15467 0 0 0 0 1479759 1987249 1749356 -269597 -269597 OTHER INCOME 900099 19464 0 0 19464 0 0 0 0 19464 2210348 0 0 -234666 617500 617500 890658 363984 192558 334116 482873 392474 33051 57348 2689 1099 581 1009 92791 37921 20061 34809 95555 39050 20659 35846 80616 34665 16929 29022 103395 103395 64710 43477 21233 0 147631 92289 45072 10270 166544 71614 34974 59956 36160 15549 7594 13017 7723 3321 1622 2780 15183 6529 3188 5466 BAD DEBT EXPENSE 48267 0 48267 0 GRANT REFUND -69641 -69641 0 0 honorarium 7000 7000 0 0 TAXES & LICENSES 3180 0 3180 0 13836 5949 2906 4981 2806670 1662780 451875 692015 159670 252478 175124 25141 1883638 1147277 207753 208761 0 0 0 0 369717 24212 59379 47991 19111 11388 2215533 2709178 9431 8855 0 336301 208089 5376278 4595379 72777 76852 172902 17571 0 0 313026 184814 558705 279237 X 2876276 2962345 1941297 1353797 4817573 4316142 5376278 4595379 -596322 94891 0 X false true true false X 2494884 4702594 3897240 2734459 2445014 16274191 0 0 2494884 4702594 3897240 2734459 2445014 16274191 1291631 14982560 15925 3501 10679 27519 15467 73091 0 0 0 0 100364 19464 119828 16467110 0 0.90985 0.9499 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - OTHER INCOME, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 0.0, COLUMN D - 100364.0, COLUMN E - 19464.0, COLUMN F - 119828.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 39479 28091 11388 19900 19900 0 11388 Federal Income Taxes OPERATING LEASE LIABILITY 184814 184814 X 2305239 94891 0 94891 2210348 0 0 2210348 2806670 0 0 2806670 0 0 2806670 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote UNDER GAAP, AN ORGANIZATION MUST RECOGNIZE THE TAX BENEFIT ASSOCIATED WITH TAX POSITIONS TAKEN FOR TAX RETURN PURPOSES WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY A TAXING AUTHORITY. THE FOUNDATION DOES NOT BELIEVE IT HAS TAKEN ANY MATERIAL UNCERTAIN TAX POSITIONS AND, ACCORDINGLY, IT HAS NOT RECORDED ANY LIABILITY FOR UNRECOGNIZED TAX BENEFITS. THE FOUNDATION HAS FILED FOR AND RECEIVED INCOME TAX EXEMPTIONS IN THE JURISDICTIONS WHERE IT IS REQUIRED TO DO SO. ADDITIONALLY, THE FOUNDATION HAS FILED INTERNAL REVENUE SERVICE FORM 990 INFORMATION RETURNS, AS REQUIRED, AND ALL OTHER APPLICABLE RETURNS IN JURISDICTIONS WHERE SO REQUIRED. FOR THE YEAR ENDED JUNE 30, 2025, THERE WERE NO INTEREST OR PENALTIES RECORDED OR INCLUDED IN THE STATEMENT OF ACTIVITIES. THE FOUNDATION IS SUBJECT TO A ROUTINE AUDIT BY A TAXING AUTHORITY. AS OF JUNE 30, 2025, THE FOUNDATION WAS NOT SUBJECT TO ANY EXAMINATION BY A TAXING AUTHORITY. X X X X true ERICA LINDEN FINEBERG 333 E 68TH STREET NEW YORK NY 10065 FUNDRAISING false 253950 25395 228555 DLBHICKS LLC 102 OVERLOOK DRIVE HACKETTSTOWN NJ 07840 FUNDRAISING false 100000 78000 22000 353950 103395 250555 NY Gala 2561560 1547182 1014378 0 41508 230599 184479 247202 310589 Hamptons Happening 390757 108630 282127 0 0 202303 56621 0 23203 5 514691 331437 183254 0 0 73338 0 0 379514 3467008 1987249 1479759 0 41508 506240 241100 247202 713306 1749356 -269597 true ICAHN SCHOOL OF MEDS AT MOUNT SIANAI ONE GUSTAE L LEVY PL NEW YORK NY 10229 136171197 501(C)(3) 112500 N/A N/A RESEARCH GRANTS THE GENERAL HOSPITAL CORP 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)(3) 100000 N/A N/A RESEARCH GRANTS CITY OF HOPE 1500 E DURATE ROADE DURANTE CA 91010 953435919 501(C)(3) 100000 N/A N/A RESEARCH GRANTS ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVENUE NEW YORK NY 10461 830621846 501(C)(3) 80000 N/A N/A RESEARCH GRANTS JOHNS HOPKINS UNIVERSITY 1650 ORLEANS STREET BALTIMORE MD 21263 520595110 501(C)(3) 75000 N/A N/A RESEARCH GRANTS UNIVERSITY OF CHICAGO 6054 S DREXEL AVE CHICAGO IL 60637 362177139 501(C)(3) 75000 N/A N/A RESEARCH GRANTS BRIGHAM AND WOMEN'S HOSPITAL RESEARCH 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 50000 N/A N/A RESEARCH GRANTS WHITEHEAD INSITUTE FOR BIOMEDICAL RES 455 MAIN ST CAMBRIDGE MA 02124 061043412 501(C)(3) 25000 N/A N/A RESEARCH GRANTS 8 0 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds ALL GRANT RECIPIENTS HAVE TO SUBMIT A FINANCIAL REPORT INDICATING HOW THE GRANT WAS SPENT, IF ALL THE FUNDS WERE NOT SPENT THIS CAN AFFECT FUTURE GRANT FUNDING TO THE RECIPIENT. X X X X false false false false false false false true false SAMUEL WAXMAN MD DIRECTOR-CEO 250000 0 0 0 0 0 0 0 0 0 250000 0 0 0 GREGORY FABIJANCZUK CFO/DIRECTOR OF FINANCE (thru 04/30/2025) 135613 0 10000 0 0 0 5388 0 37209 0 188210 0 0 0 WILLIAM T SULLIVAN EXECUTIVE DIRECTOR 342514 0 0 0 0 0 35209 0 53725 0 431448 0 0 0 KAREN KIRK DIRECTOR OF SPECIAL EVENTS 111650 0 10000 0 0 0 4283 0 68345 0 194278 0 0 0 WYLIE TENE DIRECTOR OF MARKETING & COMMUNICATION 130472 0 10000 0 0 0 5619 0 26362 0 172453 0 0 0 Suzanna C Houston Director of Special Projects 120750 0 10000 0 0 0 4606 0 26393 0 161749 0 0 0 Schedule J, Part I, Line 7 Non-fixed payments SCHEDULE J, PART II, COLUMN (B)(II) REPORTS PERFORMANCE BASED BONUSES THAT WERE DETERMINED BY THE COMPENSATION COMMITTEE AND WAS APPROVED BY THE BOARD. 4 58267 Other - FMV 0 false true false Schedule M, Part I Explanations of reporting method for number of contributions Securities - Publicly traded - THE NUMERICAL DATA IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED. Form 990, Part I, Line 1 ORGANIZATION'S MISSION STATEMENT (CONTINUATION) IN ADDITION TO SUPPORTING ONGOING COLLABORATIVE RESEARCH IN SPECIFIC CANCERS, OUR SCIENTISTS ARE INVESTIGATING THE BIOLOGY OF CANCER TO FIND TREATMENTS ACROSS DISEASE TYPES. THE WORLD CLASS SCIENTISTS WHO REPRESENTS OUR INSTITUTE WITHOUT WALLS SHARE INFORMATION AND RESOURCES TO SPEED THE PACE OF CANCER RESEARCH. FOUNDATION INVESTIGATORS HAVE MADE MAJOR BREAKTHROUGHS IN CANCER, FROM DISCOVERING PATHWAYS TO DELIVER DRUGS TO IDENTIFYING POTENTIAL MINIMALLY TOXIC AND NOVEL THERAPIES. Form 990, Part VI, Line 2 Family/business relationships amongst interested persons BOARD MEMBERS, SPENCER WAXMAN AND SCOTT WAXMAN AND SAMUEL WAXMAN, DIRECTOR-CEO. - Family relationship, BOARD MEMBERS, DENNIS A. HERMAN AND LINDA HERMAN - Family relationship Form 990, Part VI, Line 11b Review of form 990 by governing body FORM 990 WAS PREPARED BY A NATIONALLY RECOGNIZED ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. THE TREASURER AND OTHER EXECUTIVE BOARD MEMBERS ARE ACTIVELY INVOLVED WITH THE REVIEW OF THE AUDITED FINANCIAL STATEMENTS. THE FORM 990 IS REVIEWED AND COMPARED WITH THE AUDITED FINANCIAL STATEMENTS AND A COPY IS PROVIDED TO ALL BOARD MEMBERS BEFORE BEING FILED WITH IRS. Form 990, Part VI, Line 12c Conflict of interest policy THE FOUNDATION ANNUALLY, DURING JUNE'S BOARD MEETING AND PRIOR TO THE START OF THE FISCAL YEAR ON JULY 1ST, REQUESTS EVERY BOARD MEMBER, OFFICER AND KEY EMPLOYEE TO COMPLETE AND RETURN A CONFLICT OF INTEREST FORM. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE COMPENSATION COMMITTEE, WHICH COMPRISES OF BOARD MEMBERS DETERMINE THE COMPENSATION FOR THE CEO, EXECUTIVE DIRECTOR, KEY EMPLOYEES AND OFFICERS BASED UPON PERFORMANCE REVIEW SUCH AS THE CREDENTIALS, SKILLS, EXPERIENCE AND EXPERTISE REQUIRED FOR THESE POSITIONS. SURVEYS AND RESEARCH ARE DONE, INCLUDING THE COMPARISON OF OTHER ORGANIZATION'S FORM 990 TO DETERMINE THE REASONABLE COMPENSATION. THE decision is contemporaneously DOCUMENTED IN THE BOARD MINUTES. Form 990, Part VI, Line 15b Process to establish compensation of other employees THE COMPENSATION COMMITTEE, WHICH COMPRISES OF BOARD MEMBERS DETERMINE THE COMPENSATION FOR THE CEO, EXECUTIVE DIRECTOR, KEY EMPLOYEES AND OFFICERS BASED UPON PERFORMANCE REVIEW SUCH AS THE CREDENTIALS, SKILLS, EXPERIENCE AND EXPERTISE REQUIRED FOR THESE POSITIONS. SURVEYS AND RESEARCH ARE DONE, INCLUDING THE COMPARISON OF OTHER ORGANIZATION'S FORM 990 TO DETERMINE THE REASONABLE COMPENSATION. THE decision is contemporaneously DOCUMENTED IN THE BOARD MINUTES. Form 990, Part VI, Line 19 Required documents available to the public THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FOUNDATION'S AUDITED FINANCIAL STATEMENTS AND FORM 990 ARE AVAILABLE ON THE FOUNDATION'S WEBSITE (WWW.WAXMANCANCER.ORG).